Read the units against the markings on your specific syringe
In summary, while diarrhoea, reflux, and dyspepsia were monitored carefully in retatrutide studies, the data so far indicate that they are not major problems
Rodent studies have shown C-cell tumours with GLP-1 receptor agonists, but the relevance to humans is unknown
Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype
Other GLP-1 agonists include dulaglutide (Trulicity), liraglutide (Saxenda and Victoza), exenatide (Bydueron and Byetta), semaglutide (Rybelsus), and tirzepatide (Mounjaro)
We've Got The Answers Sadly, these medications are not covered by insurance, especially if you are not a diabetic